An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions

Chun Yen Liu, Pei Tsen Wu, Jing Ping Wang, Po Wei Fan, Chang Hung Hsieh, Chun Li Su, Chien Chih Chiu, Ching Fa Yao, Kang Fang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A number of effective anti-cancer drugs contain either indole or quinoline group. Compounds fused indole and quinoline moieties altogether as indolylquinoline were rarely reported as anti-cancer agents. We reported here that a synthetic indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), inhibited the growth of human non-small cell lung cancer (NSCLC) cells in dose- and time-dependent manners. The cytotoxicity was mediated through apoptotic cell death that began with mitochondrial membrane potential interruption and DNA damage. EMMQ caused transient elevation of p53 that assists in cytochrome c release, cleavage of downstream PARP and procaspase-3 and mitochondria-related apoptosis. The degree of apoptotic cell death depends on the status of tumor suppressor p53 of the target cells. H1299 cells with stable ectopic expression of p53 induced cytotoxicity by disrupting mitochondria functions that differed with those transfected with mutant p53. Knocking-down of p53 attenuated drug effects. EMMQ suppressed the growth of A549 tumor cells in xenograft tumors by exhibiting apoptosis characteristics. Given its small molecular weight acting as an effective p53 regulator in NSCLC cells, EMMQ could be an addition to the current list of lung cancer treatment.

Original languageEnglish
Pages (from-to)1471-1482
Number of pages12
JournalApoptosis
Volume20
Issue number11
DOIs
Publication statusPublished - 2015 Nov 30

Fingerprint

Tumors
Lung Neoplasms
Mitochondria
Cells
Cell death
Cytotoxicity
Apoptosis
Derivatives
Neoplasms
Oncology
Non-Small Cell Lung Carcinoma
Cytochromes c
Heterografts
Cell Death
Caspase 3
Pharmaceutical Preparations
Molecular weight
Mitochondrial Membrane Potential
Membranes
Growth

Keywords

  • Apoptosis
  • Human non-small-cell-lung-cancer cells
  • Indolylquinoline
  • RNA interference
  • p53

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Cancer Research

Cite this

An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions. / Liu, Chun Yen; Wu, Pei Tsen; Wang, Jing Ping; Fan, Po Wei; Hsieh, Chang Hung; Su, Chun Li; Chiu, Chien Chih; Yao, Ching Fa; Fang, Kang.

In: Apoptosis, Vol. 20, No. 11, 30.11.2015, p. 1471-1482.

Research output: Contribution to journalArticle

Liu, Chun Yen ; Wu, Pei Tsen ; Wang, Jing Ping ; Fan, Po Wei ; Hsieh, Chang Hung ; Su, Chun Li ; Chiu, Chien Chih ; Yao, Ching Fa ; Fang, Kang. / An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions. In: Apoptosis. 2015 ; Vol. 20, No. 11. pp. 1471-1482.
@article{446c54690840496bad4fa7bb488e0cb0,
title = "An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions",
abstract = "A number of effective anti-cancer drugs contain either indole or quinoline group. Compounds fused indole and quinoline moieties altogether as indolylquinoline were rarely reported as anti-cancer agents. We reported here that a synthetic indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), inhibited the growth of human non-small cell lung cancer (NSCLC) cells in dose- and time-dependent manners. The cytotoxicity was mediated through apoptotic cell death that began with mitochondrial membrane potential interruption and DNA damage. EMMQ caused transient elevation of p53 that assists in cytochrome c release, cleavage of downstream PARP and procaspase-3 and mitochondria-related apoptosis. The degree of apoptotic cell death depends on the status of tumor suppressor p53 of the target cells. H1299 cells with stable ectopic expression of p53 induced cytotoxicity by disrupting mitochondria functions that differed with those transfected with mutant p53. Knocking-down of p53 attenuated drug effects. EMMQ suppressed the growth of A549 tumor cells in xenograft tumors by exhibiting apoptosis characteristics. Given its small molecular weight acting as an effective p53 regulator in NSCLC cells, EMMQ could be an addition to the current list of lung cancer treatment.",
keywords = "Apoptosis, Human non-small-cell-lung-cancer cells, Indolylquinoline, RNA interference, p53",
author = "Liu, {Chun Yen} and Wu, {Pei Tsen} and Wang, {Jing Ping} and Fan, {Po Wei} and Hsieh, {Chang Hung} and Su, {Chun Li} and Chiu, {Chien Chih} and Yao, {Ching Fa} and Kang Fang",
year = "2015",
month = "11",
day = "30",
doi = "10.1007/s10495-015-1165-6",
language = "English",
volume = "20",
pages = "1471--1482",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "11",

}

TY - JOUR

T1 - An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions

AU - Liu, Chun Yen

AU - Wu, Pei Tsen

AU - Wang, Jing Ping

AU - Fan, Po Wei

AU - Hsieh, Chang Hung

AU - Su, Chun Li

AU - Chiu, Chien Chih

AU - Yao, Ching Fa

AU - Fang, Kang

PY - 2015/11/30

Y1 - 2015/11/30

N2 - A number of effective anti-cancer drugs contain either indole or quinoline group. Compounds fused indole and quinoline moieties altogether as indolylquinoline were rarely reported as anti-cancer agents. We reported here that a synthetic indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), inhibited the growth of human non-small cell lung cancer (NSCLC) cells in dose- and time-dependent manners. The cytotoxicity was mediated through apoptotic cell death that began with mitochondrial membrane potential interruption and DNA damage. EMMQ caused transient elevation of p53 that assists in cytochrome c release, cleavage of downstream PARP and procaspase-3 and mitochondria-related apoptosis. The degree of apoptotic cell death depends on the status of tumor suppressor p53 of the target cells. H1299 cells with stable ectopic expression of p53 induced cytotoxicity by disrupting mitochondria functions that differed with those transfected with mutant p53. Knocking-down of p53 attenuated drug effects. EMMQ suppressed the growth of A549 tumor cells in xenograft tumors by exhibiting apoptosis characteristics. Given its small molecular weight acting as an effective p53 regulator in NSCLC cells, EMMQ could be an addition to the current list of lung cancer treatment.

AB - A number of effective anti-cancer drugs contain either indole or quinoline group. Compounds fused indole and quinoline moieties altogether as indolylquinoline were rarely reported as anti-cancer agents. We reported here that a synthetic indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), inhibited the growth of human non-small cell lung cancer (NSCLC) cells in dose- and time-dependent manners. The cytotoxicity was mediated through apoptotic cell death that began with mitochondrial membrane potential interruption and DNA damage. EMMQ caused transient elevation of p53 that assists in cytochrome c release, cleavage of downstream PARP and procaspase-3 and mitochondria-related apoptosis. The degree of apoptotic cell death depends on the status of tumor suppressor p53 of the target cells. H1299 cells with stable ectopic expression of p53 induced cytotoxicity by disrupting mitochondria functions that differed with those transfected with mutant p53. Knocking-down of p53 attenuated drug effects. EMMQ suppressed the growth of A549 tumor cells in xenograft tumors by exhibiting apoptosis characteristics. Given its small molecular weight acting as an effective p53 regulator in NSCLC cells, EMMQ could be an addition to the current list of lung cancer treatment.

KW - Apoptosis

KW - Human non-small-cell-lung-cancer cells

KW - Indolylquinoline

KW - RNA interference

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=84942549290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942549290&partnerID=8YFLogxK

U2 - 10.1007/s10495-015-1165-6

DO - 10.1007/s10495-015-1165-6

M3 - Article

C2 - 26349782

AN - SCOPUS:84942549290

VL - 20

SP - 1471

EP - 1482

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 11

ER -